Literature DB >> 16217703

Brain MRI and proton MRS findings in infants and children with respiratory chain defects.

A Dinopoulos1, K M Cecil, M B Schapiro, A Papadimitriou, G M Hadjigeorgiou, B Wong, T deGrauw, J C Egelhoff.   

Abstract

OBJECTIVE: The aim of this study is to describe neuroimaging patterns in children with respiratory chain (RC) defects using magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (MRS) and to assess their role in the diagnostic evaluation.
METHOD: Neuroimaging studies of 49 children (newborn to 15 years old) with biochemical evidence of RC defect were reviewed. Patients were divided in 3 groups ("definite" = 24, "probable" = 14, "possible" = 11) according to Modified Adult Criteria for the diagnosis of RC defect. Eighty-one MRI studies were reviewed for deep gray and white matter changes, degree of myelination, cerebral and cerebellar atrophy, and 67 proton MRS studies were assessed for the presence or absence of lactate elevation, as well as NAA/Cr ratio. The findings were compared among the 3 groups with chi-square test.
RESULTS: All patients with "pure" myopathy had normal imaging studies. In patients with CNS involvement, significant differences in the frequency of imaging abnormalities among groups were found for deep gray matter (43 %/8 %/0 %; p = 0.01) and for the presence of lactate elevation on proton MRS (81 %/31 %/0 %; p = 0.001).
CONCLUSION: Brain MRI and proton MRS abnormalities were observed only in association with clinical CNS involvement. Deep gray matter signal abnormalities on structural imaging and lactate elevation on proton MRS were more frequently observed in the "definite" group and represent neuroimaging markers for RC mitochondriopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217703     DOI: 10.1055/s-2005-872807

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  22 in total

1.  Clinically asymptomatic adult patient with extensive LBSL MRI pattern and DARS2 mutations.

Authors:  Pierre Labauge; Imen Dorboz; Eleonore Eymard-Pierre; Olivier Dereeper; Odile Boespflug-Tanguy
Journal:  J Neurol       Date:  2010-09-29       Impact factor: 4.849

Review 2.  [Cerebral CT and MRI in mitchondrial disorders].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 3.  Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis.

Authors:  Linsheng Zhang; Sherine S L Chan; Daynna J Wolff
Journal:  Arch Pathol Lab Med       Date:  2011-07       Impact factor: 5.534

Review 4.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

5.  Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain.

Authors:  José Guevara-Campos; Lucía González-Guevara; Carmen Puig-Alcaraz; Omar Cauli
Journal:  Metab Brain Dis       Date:  2013-07-10       Impact factor: 3.584

6.  Pediatric sports-related concussion produces cerebral blood flow alterations.

Authors:  Todd A Maugans; Chad Farley; Mekibib Altaye; James Leach; Kim M Cecil
Journal:  Pediatrics       Date:  2011-11-30       Impact factor: 7.124

Review 7.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 8.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30

Review 9.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

Review 10.  Presentation and diagnosis of mitochondrial disorders in children.

Authors:  Mary Kay Koenig
Journal:  Pediatr Neurol       Date:  2008-05       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.